Articles from Investor's Business Daily

Fortinet and Boston Scientific are among five stocks near buy points.

In a welcome move, Range Resources stock saw its Relative Strength Rating improve from 69 to 72 on Friday.

Arcellx stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 79 to 82.

Best China stocks 2025: China stimulus bets and Trump tariff fears have weighed on Chinese stocks. Tesla rivals BYD and Zeekr are setting up.

Boosted by AI trends, Apple and other Mag 7 stocks notched all-time highs as the S&P 500 and Nasdaq enjoyed record years.

When we think of top innovators, we often focus on young visionaries. But some of the greatest innovators were older.

Andrea Ghez can't stop asking questions about the universe — or trying to answer them. The results made history.

Netflix reported strong viewership numbers for its Christmas Day NFL football games and Beyoncé halftime show. But Netflix stock fell Friday.

Artificial intelligence pioneer OpenAI laid out more details on plans to adopt a for-profit business structure in 2025, a move that could impact Microsoft stock.

The stock market rose solidly and broadly, but the indexes remain divided.

Reddit stock has soared 250% since its IPO in March, with analysts bullish the social media site can add to those gains in 2025.

On Thursday, Arm Holdings stock received a positive adjustment to its Relative Strength (RS) Rating, from 66 to 73.

Building your watch list? Look for stocks with an 80-plus RS Rating. Aehr Test Systems stock just met that criteria with a new score of 80.

Retirement planning for the year ahead: Lower your income tax and grow your portfolio with these smart investment strategies.

Read inspirational quotes about achieving your best, building your future and treating others with respect.

Netflix stock is worth holding as it approaches a milestone price amid a flurry of recent price targets, trader Kathy Donnelly says.

CrowdStrike stock took a hit in July when the company caused a massive outage with a cybersecurity update. It seems to have recovered.

With Apple stock in record-high territory, a longtime Apple bull on Thursday raised his price target to the highest level on Wall Street.

Uber stock was lower after regulators in Taiwan blocked its plan to acquire Delivery Hero's Foodpanda local operations for $950 million.

The company sells one drug to treat a condition that causes dry, red and itchy eyes. But rosacea and Lyme disease could be next.

Federal budget cuts in 2025 and beyond loom as a wild card for Palantir stock and software makers amid Donald Trump's DOGE initiative.

On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.

U.S. natural gas futures are trading around two-year highs as cold temperatures and potentially more LNG exports boost prices.

Chinese e-commerce giant Alibaba will form a joint-venture online shopping operation with South Korean retailer E-Mart.

Visa shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.

Neurocrine Biosciences stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 67 to 71.

Dell Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 69 to 74.

JinkoSolar Holding stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 71 to 82.

A technical issue briefly grounded American Airlines on Christmas Eve.

Honda and Nissan are in talks to merge at a time of auto industry upheaval.

Investors in old Ma Bell would be proud of the 2024 performance of AT&T stock. But can the telecom giant repeat its success next year?

Netflix stock scored a price-target hike on Tuesday ahead of the company's next big test for live programming — two NFL games.

Affirm stock has climbed 32% in 2024. Rival buy now, pay later firm Klarna plans to launch an initial public offering in 2025.

American Airlines stock fell early Tuesday after it issued a ground stop for all flights on Christmas Eve.

A few smart money resolutions can help you prepare for 2025's ups and downs. Have a diversified portfolio and focus on taxes.

Tesla's strong quarter in China continues with latest data release. Will that be enough?

Despite intensifying competition and a slight maturing in the AI market, the demand for Nvidia's AI chips is still elevated.

One key metric to look for in a stock is an 80-plus Relative Strength Rating. Roku stock now clears that threshold, with a jump to 81 Monday.

On Monday, Select Medical Holdings stock reached a key technical benchmark, seeing its RS Rating jumping to 81, up from 76 the day before.

Apple stock notched a record high after an analyst said the consumer electronics giant is likely to have strong holiday season sales.

SoundHound stock nabbed a price-target hike as an analyst sees increasing demand for the company's conversational voice AI technology.

Meta stock gained following a report that the Facebook parent is planning to add a display to its Ray-Ban AI smart glasses.

Arm stock fell while Qualcomm stock rose in response to a jury verdict in a federal court case over a technology licensing dispute.

The company could hit record Q4 deliveries but it may not mean anything for TSLA.

Here's the stock market forecast for 2025, and how the election of Donald Trump will figure into the Dow Jones, S&P 500 and Nasdaq indexes.

Lululemon holds a 90 Composite Rating, a mix of five proprietary ratings. The best growth stocks have a Composite Rating of 90 or better.

The planned consortium would take on defense giants.

The AI giant leads stocks near buy points as the postelection rally turns volatile.

The FDA signed off on Vertex's newest cystic fibrosis treatment. But it might not help beleaguered Vertex stock.

Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.

DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.

On Friday, consumer products Clorox stock got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 76.

Morgan Stanley on Friday issued a bullish report on artificial intelligence chipmakers, calling Nvidia stock a top pick for 2025.

Micron, Vertex, Novo Nordisk and Nike were notable losers on news.

Oracle stock fell Friday after an analyst downgraded the stock to sell, citing "gen AI hype" that has stretched the company's valuation.

The week ahead is a major one for Netflix stock as the internet television network broadcasts two NFL games and releases "Squid Game 2."

Palantir stock eyed a second weekly loss in a row amid questions about the artificial intelligence leader's valuation.

Here’s who qualifies and which vehicles can earn you the biggest federal EV tax credit.

The Federal Reserve's primary inflation rate, the core PCE price index, saw just a tepid rise in November after a couple of elevated readings. The S&P 500 cut its losses.

The Bitcoin price, after soaring on Trump euphoria, has gone into reverse as Treasury yields jumped.

The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.

Eli Lilly and Viking Therapeutics jumped on Novo's setback.

Legendary basketball coach and teacher John Wooden said "failing to prepare is preparing to fail." Strategic planning is the solution.

Olive Garden parent Darden Restaurants joined the Stock Spotlight list. Darden recently acquired Chuy's for $605 million cash.

Kroger's IBD Relative Strength (RS) Rating climbed to 82 Thursday. The biggest stock winners often have an 80 or better RS Rating.

Investors shrugged off the meltdown on Thursday. A few Dow laggards rebounded.

Nike reports fiscal Q2 2025 results late Thursday. The athletic retailer has been the second-worst performing stock in the Dow this year.

The Relative Strength (RS) Rating for Jabil stock climbed into a new percentile Thursday, with an increase from 73 to 85.

Duolingo stock scored a price-target hike from an analyst who is increasingly bullish on prospects for the company’s language learning app.

The stock market could be "sloppy" over the next several weeks.

The drug technically missed the study's primary goal. But there's still promise it could work in specific patients.

Apple is reportedly in talks with Chinese technology firms Tencent and ByteDance about using their AI models. Tencent stock gained.

C3.ai stock was downgraded by KeyBanc analysts who cited revenue growth concerns at the AI software company.

Strong sales of memory chips for data centers weren't enough to offset weakness in PC and smartphone markets for Micron in Q1. MU stock fell.

An Uber stock analyst with Oppenheimer says the ride-hail market leader's recent sell-off presents an opportunity for investors.